Enhancement updates provide short alerts to new, fixed or improved Connect Care functions...
- Updates to Paraneoplastic Syndrome Plus Order
As of July 7, 2026, changes will be implemented to optimize the Paraneoplastic Syndrome ordering workflow within Connect Care including updated process instructions, new mandatory questions, order validation (hard stops), and updated ordering guidance based on selections in the Paraneoplastic Neurological Syndrome Plus order composer. These changes support improved clinical and operational consistency by aligning ordering workflows with updated clinical and lab requirements, improving clarity and accuracy of test selection, and supporting standardized ordering across prescribers. Any previous personalization of the order will need to be updated after the change; tips on re-personalization following the change are below.
- New ordering question added: "Does the patient have one of the following high or medium risk paraneoplastic clinic syndromes (if yes, select the corresponding phenotype)?"
- Additional cascading questions: If "None of the Above" is selected in the new question, a question will then appear to indicate the ordering decision for testing outside of high or medium phenotypes. Further questions will then cascade depending on the selection (click the camera icon to see screenshots of different ordering scenarios).
- How to re-personalize the order: Re-personalization will be required to incorporate updates made to the order:
- Locate the order in the Preference List under the "My Favorites" section.
- Right-click the order and select "Edit Preference List Entry".
For assistance or additional training, please contact the CMIO Prescriber Experience Team at
help.cmio@hssab.ca.
